| 0002-4178-62 |
0002-4178 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
.8 mg/1 |
1 BOTTLE in 1 CARTON (0002-4178-62) / 30 TABLET, FILM COATED in 1 BOTTLE |
| 0002-4178-31 |
0002-4178 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
.8 mg/1 |
1 BOTTLE in 1 CARTON (0002-4178-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4178-01) |
| 0002-4794-31 |
0002-4794 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
5.5 mg/1 |
1 BOTTLE in 1 CARTON (0002-4794-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4794-01) |
| 0002-4953-31 |
0002-4953 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
17.2 mg/1 |
1 BOTTLE in 1 CARTON (0002-4953-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4953-01) |
| 0002-4503-31 |
0002-4503 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
2.5 mg/1 |
1 BOTTLE in 1 CARTON (0002-4503-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4503-01) |
| 0002-4803-31 |
0002-4803 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
9 mg/1 |
1 BOTTLE in 1 CARTON (0002-4803-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4803-01) |
| 0002-4839-31 |
0002-4839 |
HUMAN PRESCRIPTION DRUG |
FOUNDAYO |
orforglipron |
TABLET, FILM COATED |
ORAL |
20260401 |
N/A |
NDA |
NDA220934 |
Eli Lilly and Company |
ORFORGLIPRON CALCIUM |
14.5 mg/1 |
1 BOTTLE in 1 CARTON (0002-4839-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4839-01) |